BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23396962)

  • 1. Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.
    Hoffman AE; Demanelis K; Fu A; Zheng T; Zhu Y
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):736-44. PubMed ID: 23396962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.
    Jiao J; Zheng T; Lan Q; Chen Y; Deng Q; Bi X; Kim C; Holford T; Leaderer B; Boyle P; Ba Y; Xia Z; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2012 Nov; 21(6):580-4. PubMed ID: 22430443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.
    Nielsen KR; Steffensen R; Bendtsen MD; Rodrigo-Domingo M; Baech J; Haunstrup TM; Bergkvist KS; Schmitz A; Boedker JS; Johansen P; Dybkaeær K; Boeøgsted M; Johnsen HE
    PLoS One; 2015; 10(10):e0139329. PubMed ID: 26448050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
    Lossos IS; Natkunam Y; Levy R; Lopez CD
    Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
    Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
    PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
    Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.
    Keshavarz P; Inoue H; Nakamura N; Yoshikawa T; Tanahashi T; Itakura M
    Mol Genet Metab; 2008 Feb; 93(2):200-9. PubMed ID: 17950019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.
    Randrianarisoa E; Lehn-Stefan A; Krier J; Böhm A; Heni M; Hrabě De Angelis M; Fritsche A; Häring HU; Stefan N; Staiger H
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31512724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.
    Sproul K; Jones MR; Azziz R; Goodarzi MO
    Eur J Endocrinol; 2009 Sep; 161(3):405-9. PubMed ID: 19574280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.
    Maskarinec G; Erber E; Gill J; Cozen W; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):196-203. PubMed ID: 18187389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.
    Salles G; Gopal AK; Minnema MC; Wakamiya K; Feng H; Schecter JM; Wang M
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):275-284. PubMed ID: 30795996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of non-Hodgkin's lymphoma.
    Nogai H; Dörken B; Lenz G
    J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
    Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.